Latest AI and machine learning research in leukemia for healthcare professionals.
Artificial intelligence (AI) has impacted healthcare at urban and academic medical centers globally. The current focus on AI deployments in urban areas and the history of US urban-rural digital divides raises concerns that the promise of AI may not be realized in rural communities. This may exacerbate well-documented health disparities. Without the benefits of AI-driven improvements in patient out...
Hepatic steatosis (HS) is a common cardiometabolic risk factor frequently present but under-diagnosed in patients with suspected or known coronary artery disease. We used artificial intelligence (AI) to automatically quantify hepatic tissue measures for identifying HS from CT attenuation correction (CTAC) scans during myocardial perfusion imaging (MPI) and evaluate their added prognostic value for...
The European LeukemiaNet (ELN) risk stratification of acute myeloid leukemia (AML) uses genetic and molecular markers to categorize patients. However,...
Chronic pain is a major healthcare problem associated with maladaptive brain circuit changes - many patients are unresponsive to all available therapi...
Pre-procedural risk prediction of 30-day all-cause mortality after percutaneous coronary intervention (PCI) aids in clinical decision-making and bench...
Rare haematological diseases (RHD) pose significant clinical challenges due to their heterogeneity, limited patient populations, and fragmented datase...
The dire consequences of heart failure (HF) patient non-response to guideline directed medical therapy often fuel early, non-selective referral for su...
Acute Myeloid Leukemia (AML) is a genetically and clinically heterogeneous disease that can develop at any age. While AML incidence increases with age...
The objective of this study was to develop a flexible risk stratification strategy for Acute Myeloid Leukemia (AML) that is specific for venetoclax pl...
Early-onset colorectal cancer (EOCRC), defined as diagnosis before age 50, is rising rapidly and disproportionately affects high-risk populations, par...
Deep learning models applied to digital histology can predict gene expression signatures (GES) and offer a low-cost, rapidly available alternative to ...
A hallmark of glioblastoma (GBM) is disease recurrence, which occurs in all patients despite tumor resection, radiation, and chemotherapy. A critical ...
Acute ischemic stroke (AIS) management has evolved substantially over the past two decades, with mechanical thrombectomy adding complexity that requir...
The health consequences of ionizing radiation have long been studied, yet significant uncertainties remain, particularly at low doses. In particular, ...
Acute stroke alerts are often activated for non-cerebrovascular conditions, leading to false positives that strain clinical resources and promote diag...
Acute lymphoblastic leukemia is a highly heterogeneous hematologic malignancy that poses significant challenges for clinicians in terms of early detec...
We overcome current limitations in Acute Myeloid Leukemia (AML) diagnosis by leveraging a transfer learning approach from Acute Lymphoblastic Leukemia...
Spinal cord injury (SCI) remains a devastating neurological condition with high global incidence and minimal curative options. The pathobiology is mul...
Congenital heart defects afflict nearly 1% of all births worldwide. While deep learning algorithms have shown significant promise in automating and im...
Survivors of myocardial infarction (MI) are still at risk for adverse long-term outcomes such as all-cause mortality, heart failure (HF), and ischemic...